Learn to sell on Amazon with our step-by-step guide—from account setup to shipping and promos, get all you need to launch ...

How new diagnostic pathways can support earlier diagnosis and appropriate management in patients with lower gastrointestinal ...

Even though it’s hidden from view, the New Moon marks the start of a brand-new lunar cycle—and symbolically, a fresh beginning for each of us. Its energy encourages us to set intentions, refocus our ...

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Viral Weight Loss Story: Woman Who Lost 40 Kg Shares 3 Mistakes From School Days That Made Her "Obese" Raksha Bhalavi went from 116 kg to 70 kg in just 13 months, and her inspiring weight loss ...

A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial ...

Common GLP-1 weight loss drugs - including Wegovy and Ozempic - may not work for everyone in a “real-world” setting, Cleveland Clinic researchers said Tuesday. The reason is that patients may ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing alcohol use, though high costs may limit broad access.

Then the weight returned. After further weight gain, Lloyd underwent bariatric surgery in 2022, dropping a substantial amount of weight but less than the median. She felt judged by others.

Jazz Jennings, the star of TLC's "I Am Jazz," has spoken up about her weight loss and health journey over the years. Here's everything to know about Jazz Jennings' 100-lb. weight loss.

Credit: Shutterstock Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks.